rs191559595

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_019066.5(MAGEL2):​c.383T>C​(p.Leu128Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00139 in 1,534,806 control chromosomes in the GnomAD database, including 21 homozygotes. In-silico tool predicts a benign outcome for this variant. 8/12 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0077 ( 13 hom., cov: 34)
Exomes 𝑓: 0.00071 ( 8 hom. )

Consequence

MAGEL2
NM_019066.5 missense

Scores

1
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.31

Publications

2 publications found
Variant links:
Genes affected
MAGEL2 (HGNC:6814): (MAGE family member L2) Prader-Willi syndrome (PWS) is caused by the loss of expression of imprinted genes in chromosome 15q11-q13 region. Affected individuals exhibit neonatal hypotonia, developmental delay, and childhood-onset obesity. Necdin (NDN), a gene involved in the terminal differentiation of neurons, localizes to this region of the genome and has been implicated as one of the genes responsible for the etiology of PWS. This gene is structurally similar to NDN, is also localized to the PWS chromosomal region, and is paternally imprinted, suggesting a possible role for it in PWS. [provided by RefSeq, Oct 2010]
MAGEL2 Gene-Disease associations (from GenCC):
  • Schaaf-Yang syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Illumina, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0052521825).
BP6
Variant 15-23647360-A-G is Benign according to our data. Variant chr15-23647360-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 158814.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00767 (1151/150162) while in subpopulation AFR AF = 0.0271 (1103/40696). AF 95% confidence interval is 0.0258. There are 13 homozygotes in GnomAd4. There are 525 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High AC in GnomAd4 at 1151 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAGEL2NM_019066.5 linkc.383T>C p.Leu128Pro missense_variant Exon 1 of 1 ENST00000650528.1 NP_061939.3 Q9UJ55

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAGEL2ENST00000650528.1 linkc.383T>C p.Leu128Pro missense_variant Exon 1 of 1 NM_019066.5 ENSP00000497810.1 Q9UJ55

Frequencies

GnomAD3 genomes
AF:
0.00766
AC:
1149
AN:
150048
Hom.:
13
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0271
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00191
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000593
Gnomad OTH
AF:
0.00725
GnomAD2 exomes
AF:
0.00162
AC:
228
AN:
140536
AF XY:
0.00122
show subpopulations
Gnomad AFR exome
AF:
0.0282
Gnomad AMR exome
AF:
0.000652
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000348
Gnomad OTH exome
AF:
0.00166
GnomAD4 exome
AF:
0.000706
AC:
978
AN:
1384644
Hom.:
8
Cov.:
32
AF XY:
0.000591
AC XY:
404
AN XY:
683246
show subpopulations
African (AFR)
AF:
0.0258
AC:
814
AN:
31582
American (AMR)
AF:
0.000813
AC:
29
AN:
35684
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25166
East Asian (EAS)
AF:
0.0000280
AC:
1
AN:
35724
South Asian (SAS)
AF:
0.0000379
AC:
3
AN:
79232
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
34840
Middle Eastern (MID)
AF:
0.000352
AC:
2
AN:
5686
European-Non Finnish (NFE)
AF:
0.0000343
AC:
37
AN:
1078824
Other (OTH)
AF:
0.00159
AC:
92
AN:
57906
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
68
135
203
270
338
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00767
AC:
1151
AN:
150162
Hom.:
13
Cov.:
34
AF XY:
0.00716
AC XY:
525
AN XY:
73368
show subpopulations
African (AFR)
AF:
0.0271
AC:
1103
AN:
40696
American (AMR)
AF:
0.00191
AC:
29
AN:
15178
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3452
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4982
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4700
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10474
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
282
European-Non Finnish (NFE)
AF:
0.0000593
AC:
4
AN:
67422
Other (OTH)
AF:
0.00718
AC:
15
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
58
115
173
230
288
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00440
Hom.:
3
Bravo
AF:
0.00850
ExAC
AF:
0.00222
AC:
50
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 10, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
Jan 08, 2014
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 05, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
22
DANN
Benign
0.58
DEOGEN2
Benign
0.15
T;T
FATHMM_MKL
Benign
0.10
N
LIST_S2
Benign
0.33
.;T
MetaRNN
Benign
0.0053
T;T
PhyloP100
1.3
PrimateAI
Uncertain
0.79
T
Sift4G
Benign
0.27
T;.
Vest4
0.52
MVP
0.043
GERP RS
2.6
Varity_R
0.26
gMVP
0.091

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs191559595; hg19: chr15-23892507; API